Fusarium

<!— Auto-created stub from Rule 13 scope discovery. 6 source pages mention this taxon. Awaiting content expansion. —>

References (7)

  1. Yichao Shi, Jianfeng Li, Shuntian Cai et al. (2023). Shi 2023 — PPI-Induced Fungal Dysbiosis in Patients with Gastroesophageal Reflux Disease. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2023.1205348
  2. Ane Otaegui-Chivite, Miriam Gorostidi-Aicua, Laura Martins-Almeida et al. (2025). Exploring the Mycobiota in Multiple Sclerosis: Its Influence on Disease Development and Progression. Frontiers in Immunology. doi:10.3389/fimmu.2025.1625794
  3. Ting Ding, Chang Liu, Zhengyu Li (2025). The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications. Molecular Cancer. doi:10.1186/s12943-025-02227-8
  4. Yin G, Chen F, Chen G et al. (2022). Yin 2022 — Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals. Journal of Ovarian Research. doi:10.1186/s13048-022-01051-8
  5. Nelson Mok, Natalie C. Knox, Feng Zhu et al. (2024). The Fungal Gut Microbiota in Pediatric-Onset Multiple Sclerosis. Frontiers in Microbiology. doi:10.3389/fmicb.2024.1258978
  6. Xiaoyu Wei, Zixin Guo, Jingyang Wang et al. (2025). Gut mycobiome in cardiometabolic disease progression: current evidence and future directions. Frontiers in Microbiology. doi:10.3389/fmicb.2025.1659654
  7. Xiaoyu Wei, Zixin Guo, Jingyang Wang et al. (2025). Gut Mycobiome in Cardiometabolic Disease Progression: Current Evidence and Future Directions. Frontiers in Microbiology. doi:10.3389/fmicb.2025.1659654